ZUR ROSE GROUP AG

Corporation with Board of Directors
Frauenfeld, Switzerland
Closing date: December 31
Date of the Last Annual General Meeting: April 29 2021
- E&B Pharmaceuticals & Biotechnology
- The valuable 500

Governance leadership structure

Board of Directors

Stefan FEUERSTEIN
Chair
Since about 11 years

Other directorships

7 voting members without any non-voting

Independents
Executives
Employees representatives
State representatives
Other

Directors
average seniority 12.5 years
12.6 years for elected by shareholders

Directors
average age 59.7 years
59.8 years for elected by shareholders

Chair and CEO roles are separated:
Are all of the Remuneration Committee members independent?	No

7 members

Group Management

Walter OBERHÄNSLI
Chief Executive Officer
Since over 17 years
Other directorships

Board & Leadership

Board of Directors

Your Internet Explorer version is outdated. Upgrade it, or download Google Chrome for a better experience.